Breye Therapeutics Revenue

Pharmaceutical Manufacturing • Denmark • 1-10 Employees

Breye Therapeutics revenue & valuation

Annual revenue	$855,550
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$2,800,000
Total funding	No funding

Key Contacts at Breye Therapeutics

Chiara Liberati

Member Board Of Directors

Gabriela Burian

Member Board Of Directors

Ulrik Mouritzen

Chief Executive Officer

Company overview

Headquarters	Denmark
Phone number	+4540279865
Website	breye.com
NAICS	3254
Founded	2019
Employees	1-10

About Breye Therapeutics

Our mission is to provide more effective and globally reaching treatment solutions for patients at risk of vision loss and blindness by developing orally administered therapies for patients with deteriorating vision from retinal vascular diseases within ophthalmology. With a focus on diabetic retinopathy (DR) and age-related macular degeneration (AMD), we are developing novel oral therapies to address very large unmet needs and meet physicians’ requests for more effective treatments, earlier intervention and with less burden on patients to improve outcomes.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

C-Suite

Head

Employees by Department

Breye Therapeutics has 3 employees across 3 departments.

Departments

Number of employees

Funding Data

Breye Therapeutics has never raised funding before.

Breye Therapeutics Tech Stack

Discover the technologies and tools that power Breye Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Cookie Information

Cookie compliance

jQuery

JavaScript libraries

GoDaddy

Hosting

HTTP/3

Miscellaneous

PHP

Programming languages

HSTS

Security

WordPress

Blogs

Google Maps

Maps

MySQL

Databases

RSS

Miscellaneous

Google Font API

Font scripts

Frequently asked questions

Breye Therapeutics is located in DK.

You can reach Breye Therapeutics at +4540279865.

Breye Therapeutics generates an estimated annual revenue of $855,550. This revenue figure reflects the company's market position and business performance in its industry.

Breye Therapeutics has an estimated valuation of $2,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Breye Therapeutics was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Breye Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at Breye Therapeutics

Chiara Liberati

Member Board Of Directors

Gabriela Burian

Member Board Of Directors

Ulrik Mouritzen

Chief Executive Officer

4.8

40,000 users